English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Talk

Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines

MPS-Authors
/persons/resource/persons86517

Wolff,  M.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

/persons/resource/persons86343

Kalbfuss,  B.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86531

Zimmermann,  A.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U. (2005). Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Talk presented at Viral Vectors and Vaccines Conference. Austin, Texas. 2005-11-14 - 2005-11-16.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0013-9B7B-B
Abstract
The increasing demand for cell culture based production of influenza virus vaccines requires the development of new purification strategies that are adapted to the altered upstream conditions. This workshop presents a modular purification scheme including two chromatography operations for whole-virion purification of human influenza A virus as a model system.